Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex

Mazdak Radjainia, Jae-Kyung Hyun, Clinton E. Leysath, Stephen H. Leppla, Alok K Mitra

Research output: Contribution to journalArticleResearchpeer-review

14 Citations (Scopus)

Abstract

The tripartite protein exotoxin secreted by Bacillus anthracis, a major contributor to its virulence and anthrax pathogenesis, consists of binary complexes of the protective antigen (PA) heptamer (PA63h), produced by proteolytic cleavage of PA, together with either lethal factor or edema factor. The mouse monoclonal anti-PA antibody 1G3 was previously shown to be a potent antidote that shares F C domain dependency with the human monoclonal antibody MDX-1303 currently under clinical development. Here we demonstrate that 1G3 instigates severe perturbation of the PA63h structure and creates a PA supercomplex as visualized by electron microscopy. This phenotype, produced by the unconventional mode of antibody action, highlights the feasibility for optimization of vaccines based on analogous structural modification of PA63h as an additional strategy for future remedies against anthrax.

Original languageEnglish
Pages (from-to)14070-14074
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume107
Issue number32
DOIs
Publication statusPublished - 10 Aug 2010

Keywords

  • Anthrax toxin
  • Neutralizing antibody 1G3
  • Passive immunization
  • Protein therapeutics
  • Single-particle analysis

Cite this